Johnson & Johnson (JNJ) Stock Analysis & Investment Frameworks
Johnson & Johnson (JNJ) stock analysis on Invetso. Review Johnson & Johnson’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Johnson & Johnson Company Overview
- Exchange: New York Stock Exchange
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Country: US
Johnson & Johnson Key Financial Metrics
- Market Cap: $621.22B
- Revenue: $94.19B
- P/E Ratio: 23.18
- ROE: 19.55%
- ROIC: 15.36%
- Dividend Yield: 2.05%
About Johnson & Johnson
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Johnson & Johnson Investment Frameworks
Invetso analyzes Johnson & Johnson (JNJ) across the following frameworks:
- Johnson & Johnson 10Y Growth Potential
- Johnson & Johnson Scenario Analysis
- Johnson & Johnson Risks & Opportunities
- Johnson & Johnson Economic Moat
- Johnson & Johnson Business Model
- Johnson & Johnson Management
- Johnson & Johnson SWOT Analysis
- Johnson & Johnson Porter's 5 Forces
- Johnson & Johnson PESTLE Analysis
- Johnson & Johnson ESG Analysis